Matthias Saar

12PUBLICATIONS
24CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersDisease surveillanceMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 28, 2026
Baseline PSMA PET/CT Biomarkers for Patient Selection in [177Lu]Lu-PSMA Radioligand Therapy: Clinical Promise, Methodological Heterogeneity and Future Standardization.

|Dec 26, 2025
Effects of Prior Local Therapy by Radical Prostatectomy or Radiotherapy on the Efficacy and Quality of Life of Patients Treated With Darolutamide in ARAMIS.

Matthias Saar, Karim Fizazi, Neal D Shore

|Feb 26, 2025
Mechanism of Action and Interaction of Garlic Extract and Established Therapeutics in Prostate Cancer.

Marco Hoffmann, Jana Sauer, Marie Book

|Jun 19, 2024
Therapeutic and Diagnostic Potential of Folic Acid Receptors and Glycosylphosphatidylinositol (GPI) Transamidase in Prostate Cancer.

Marco Hoffmann, Thomas Frank Ermler, Felix Hoffmann

|Jul 29, 2023
Do or Don't: Results of a Multinational Survey on Antibiotic Prophylaxis in Urodynamics.

Fabian P Stangl, Laila Schneidewind, Florian M Wagenlehner

|Jul 14, 2023
SCARA5 Is Overexpressed in Prostate Cancer and Linked to Poor Prognosis.

Fidelis Andrea Flockerzi, Johannes Hohneck, Matthias Saar

Pageof 2

Frequent Collaborators

1 joint publications

Turkan Hajili

1 joint publications

Carsten H Ohlmann

1 joint publications

Martin Janssen

1 joint publications

Ahmed S Elsayed